RecruitingPhase 4

Comparison of Outcomes of Management of Bowel Obstruction

United States550 participantsStarted 2026-02-03

Plain-language summary

The Comparison of Outcomes of Management of Bowel Obstruction (COMBO) trial is a patient-level randomized trial of a short course of dexamethasone + supportive care vs supportive care alone for patients with adhesion-related small bowel obstruction (aSBO). The goal of the COMBO trial is to answer the question: Can Dexamethasone increases the proportion of patients with resolution of aSBO with non-operative management (without complication) based on an established minimal important clinical difference.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. CT findings consistent with diagnosis of SBO; and
✓. signs and symptoms consistent with SBO; and
✓. Adhesions from prior abdominopelvic surgery are the likely cause of SBO (absence of incarcerated hernia, internal hernia, masses, fistula, stricture, volvulus, acute episode of inflammatory bowel disease (IBD) flare, etc.).

What they're measuring

Resolution of adhesive Small Bowel Obstruction (aSBO)

Timeframe: 30 days

Trial details

NCT IDNCT07084441

SponsorUniversity of Washington

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-06

Contact for this trial

Kelsey Pullar, MPH

206.221.8247 kpullar@uw.edu

View on ClinicalTrials.gov More Adhesive Small Bowel Obstruction trials